Clinical Utility Study for Exo-PDAC

首次发布于 2023 年 1 月 27 日

Comparative Effectiveness of CTC & OC

计划入组 244 人 · 首次发布于 2014 年 5 月 20 日

hUC-MSC-Exo Therapy for Autoimmune Encephalitis

计划入组 38 人 · 首次发布于 2025 年 8 月 20 日

OC-501

EXO-226

EXO-050

Exo Biologics

Belgium

FIRST OC DERMATOLOGY RESEARCH, INC.

United States

Mundipharma EDO GmbH

Switzerland

INOVIQ Secures Exclusive Global Rights to University of Queensland's Ovarian Cancer Biomarker Technology

1cBio Licenses Preclinical PARP1 Inhibitor OC-3 to Lee's Pharm for Greater China and Southeast Asia in Deal Worth Up to $27 Million

TROP2-Directed ADCs Show Promise in Recurrent Gynecological Cancers